Condition: Chronic Obstructive Pulmonary Disease Severe · Interstitial Lung Disease · Chronic Respiratory Failure With Hypoxia · Sponsor: Skane University Hospital
This is a registry-based, randomized, controlled clinical trial of the effect of added high-flow oxygen therapy (using the device Lumis HFT) during one year in people with long-term oxygen therapy (LTOT) for chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD).
This description comes directly from the study's public registry record.
Magnus Ekström, MD, PhD · 0455731000 · magnus.ekstrom@med.lu.se
Always discuss trial participation with your own doctor first.
| Research Unit, Blekinge University of Technology | Karlskrona, Blekinge County, Sweden | Recruiting |
| Department of Heart, Lung and Clinical Physiology, Örebro University Hospital | Örebro, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06247397